Regardless of the mutational status, the activation of NOTCH1 signaling, through interactions with its surface ligands, might render B-CLL cells more resistant to spontaneous and chemotherapy-induced apoptosis [13–15]. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.